Scott Dunseth Myers

Companies

• Zentalis Pharmaceuticals, Inc.Board member Nov 13, 2024 to now¹
• DYNAVAX TECHNOLOGIES CORPBoard member Oct 21, 2021 to now²
• Harpoon Therapeutics, Inc.Board member Feb 7, 2019 to Mar 11, 2024³
• Selecta Biosciences (United States)Board member Jun 18, 2019 to Nov 15, 2023⁴
• Viridian Therapeutics, Inc.\DEBoard member Feb 7, 2023 to Apr 12, 2023⁵
• Viridian Therapeutics, Inc.\DEChief executive officer Feb 7, 2023 to Apr 12, 2023⁵
• Trillium Therapeutics Inc.Board member May 5, 2021 to Nov 19, 2021⁶
• AMAG PharmaceuticalsBoard member Apr 30, 2020 to Nov 17, 2020⁷
• AMAG PharmaceuticalsChief executive officer Apr 30, 2020 to Nov 17, 2020⁷
• AMAG PharmaceuticalsPresident Apr 30, 2020 to Nov 17, 2020⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTViridian Therapeutics, Inc.\DE VRDN259,500 shares⁸$5.4M at $20.72Apr 12, 2023
• ZPZentalis Pharmaceuticals, Inc. ZNTL395,895 shares⁹$906.6K at $2.29Jun 16, 2026
• DTDYNAVAX TECHNOLOGIES CORP0 shares¹⁰Feb 10, 2026
• HTHarpoon Therapeutics, Inc.0 shares¹¹Mar 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 57,100 shares of Zentalis Pharmaceuticals, Inc.⁹
• Feb 10, 2026Returned to company 31,204 shares of DYNAVAX TECHNOLOGIES CORP¹⁰
• Feb 10, 2026U 3,800 shares of DYNAVAX TECHNOLOGIES CORP¹⁰
• Aug 22, 2025Bought 3,800 shares at $10.82 of DYNAVAX TECHNOLOGIES CORP¹²
• Jun 17, 2025Granted 57,603 shares of Zentalis Pharmaceuticals, Inc.¹³
• Jun 11, 2025Granted 5,758 shares of DYNAVAX TECHNOLOGIES CORP¹⁴
• Apr 30, 2025Bought 21,000 shares at $1.40 of Zentalis Pharmaceuticals, Inc.¹⁵
• Nov 13, 2024Granted 260,192 shares of Zentalis Pharmaceuticals, Inc.¹⁶
• May 23, 2024Granted 5,357 shares of DYNAVAX TECHNOLOGIES CORP¹⁷
• Mar 11, 2024Returned to company 22,665 shares of Harpoon Therapeutics, Inc.¹¹
• Jan 1, 2024Granted 2,048 shares of Harpoon Therapeutics, Inc.¹⁸
• Nov 27, 2023Granted 5,000 shares of Harpoon Therapeutics, Inc.¹⁹
• Oct 1, 2023Granted 5,797 shares of Harpoon Therapeutics, Inc.²⁰
• Jul 1, 2023Granted 35,634 shares of Harpoon Therapeutics, Inc.²¹
• May 26, 2023Granted 5,357 shares of DYNAVAX TECHNOLOGIES CORP²²
• Apr 12, 2023Bought 4,000 shares at $25.37 of Viridian Therapeutics, Inc.\DE⁸
• Apr 1, 2023Granted 34,925 shares of Harpoon Therapeutics, Inc.²³
• Mar 13, 2023Bought 5,500 shares at $29.15 of Viridian Therapeutics, Inc.\DE²⁴
• Feb 6, 2023Granted 250,000 shares of Viridian Therapeutics, Inc.\DE²⁵